Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media

C H Jang1, S Y Park

  • 1Wonkwang Medical School, Iksan, South Korea. chul@wonkwang.ac.kr

Insights

Chronic suppurative otitis media (CSOM) treatment with ciprofloxacin failed in all patients due to resistant Pseudomonas aeruginosa. Imipenem showed the highest effectiveness against these resistant bacteria.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Microbiology

Background:

  • Chronic suppurative otitis media (CSOM) frequently involves Pseudomonas aeruginosa.
  • Topical ciprofloxacin is a common treatment for P. aeruginosa infections.
  • Recurrent otorrhoea in CSOM can indicate treatment failure.

Purpose of the Study:

  • To evaluate patients with recurrent otorrhoea due to CSOM unresponsive to topical ciprofloxacin.
  • To identify the causative organisms and their antibiotic susceptibility patterns.

Main Methods:

  • Retrospective review of 88 patients with CSOM and otorrhoea.
  • Bacteriological specimens processed and identified via standard cultures.
  • In vitro antimicrobial susceptibility testing using agar disc diffusion against 16 antibiotics.

Main Results:

  • Pseudomonas aeruginosa resistant to ciprofloxacin was isolated in all cases.
  • Imipenem demonstrated the highest susceptibility rate (96.5%).
  • Other effective agents included amikacin (55.6%), piperacillin/tazobactam (37.5%), and ceftazidime (31.8%).

Conclusions:

  • Ciprofloxacin resistance in P. aeruginosa causing CSOM is increasing.
  • Continuous surveillance of antimicrobial resistance is crucial.
  • Alternative antibiotic therapies are needed for ciprofloxacin-resistant infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...